GW Pharmaceuticals plc
Pharmaceutical ManufacturingCambridge, United Kingdom1001-5000 Employees
GW Pharmaceuticals is now part of Jazz Pharmaceuticals. Follow us at https://www.linkedin.com/company/jazz-pharmaceuticals
Recent Expansions Jazz Pharmaceuticals has been making strategic moves in recent months, including investments from Algert Global LLC and SEC, as well as promoting key personnel like Samantha Pearce to chief commercial officer. These expansions indicate potential growth opportunities for sales and partnerships.
Mergers & Acquisitions Jazz Pharmaceuticals sold assets to Axsome Therapeutics Inc. in the past, showcasing a proactive approach towards mergers and acquisitions. This history suggests a willingness to engage in further M&A activities, presenting opportunities for sales around collaboration or new product lines.
Commitment to Innovation With a focus on developing life-changing medicines for serious diseases, Jazz Pharmaceuticals demonstrates a strong commitment to innovation. This dedication can be leveraged to create sales narratives around cutting-edge treatments and solutions, appealing to healthcare providers and patients alike.
Financial Stability Jazz Pharmaceuticals falls within the revenue range of $100M - 1B, indicating healthy financial standing. This stability can be used as a leverage point in sales discussions, showcasing reliability and capacity for sustained partnerships or investments.
Market Positioning In the realm of pharmaceutical manufacturing, Jazz Pharmaceuticals competes with companies like Canopy Growth Corporation, Zynerba Pharmaceuticals, and Cara Therapeutics. Understanding the competitive landscape can help identify market niches or opportunities to differentiate products, enhancing sales strategies.
GW Pharmaceuticals plc uses 8 technology products and services including Bloomberg, Databricks, Alation, and more. Explore GW Pharmaceuticals plc's tech stack below.
GW Pharmaceuticals plc Email Formats | Percentage |
FLast@gwpharm.com | 85% |
First.Last@gwpharm.com | 11% |
FirstL@gwpharm.com | 2% |
First-Last@gwpharm.com | 1% |
FL@gwpharm.com | 1% |
First.Last@jazzpharma.com | 78% |
FLast@jazzpharma.com | 20% |
First.Middle@jazzpharma.com | 2% |
Pharmaceutical ManufacturingCambridge, United Kingdom1001-5000 Employees
GW Pharmaceuticals is now part of Jazz Pharmaceuticals. Follow us at https://www.linkedin.com/company/jazz-pharmaceuticals
GW Pharmaceuticals plc has raised a total of $345M of funding over 6 rounds. Their latest funding round was raised on Oct 02, 2018 in the amount of $345M.
GW Pharmaceuticals plc's revenue is in the range of $100M$1B
GW Pharmaceuticals plc has raised a total of $345M of funding over 6 rounds. Their latest funding round was raised on Oct 02, 2018 in the amount of $345M.
GW Pharmaceuticals plc's revenue is in the range of $100M$1B